CVRdatabase
Menu

Orifarm Generics A/S

Public limited companyCVR 25674030Odense SActive

Orifarm Generics A/S is a public limited company, based in Odense S, active in wholesale of medical and hospital supplies, founded in 2000. Net profit rose 29% from 2024 to 2025, ending at DKK 77.2m. Measured by gross profit, it ranks no. 1 of 187 companies in the industry in the database. With 255 employees, the company is about 51 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 2.5bn+5.1% vs. 2024
Net profitDKK 77.2m+28.9% vs. 2024
EquityDKK 496.3m−10.5% vs. 2024
Employees255latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 10% (2024 → 2025), to DKK 399.8m.
  • Revenue rose 5% (2024 → 2025), to DKK 2.5bn.
  • Net profit rose 29% (2024 → 2025), to DKK 77.2m.
  • Equity fell 10% (2024 → 2025), to DKK 496.3m.

Employees

  • 26 fewer employees than a year earlier: 255 (07/2026) against 281 (07/2025).

Management and owners, last 24 months

  • New in management: Mads Fink Eriksen (board member, 17/03/2025), Thomas Brandhof (ceo, 03/09/2025) and Nicki Lund Kristensen (board member, 20/10/2025).
  • Stepped down: Erik Sandberg (board member, 17/03/2025) and Karsten Haumann (ceo, 03/09/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 100mDKK 200mDKK 300mDKK 400mDKK 500mDKK 600m202020212022202320242025
EquityNet profit
Financial figures for Orifarm Generics A/S
202020212022202320242025Change
Revenue688,4261,757,3482,074,8322,137,9302,343,0032,463,585+5.1%
Gross profit274,178329,329261,488344,529362,041399,753+10.4%
Operating profit (EBIT)185,611180,64869,55395,63099,056108,161+9.2%
Profit before tax186,687190,74969,53480,26177,04298,857+28.3%
Net profit145,514150,14054,46262,92859,86077,177+28.9%
Total assets455,7841,172,1261,345,1791,382,4061,040,2841,258,605+21%
Equity201,194527,257431,719494,647554,507496,304−10.5%
Liabilities244,217634,665903,030876,907473,102751,382+58.8%
Cash and cash equivalents–16,2402,791110287171−40.4%
Average number of employees117181228289277247−10.8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250mDKK 300mDKK 350mDKK 400m202020212022202320242025
Gross profitMedian, the industry (187 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Orifarm Generics A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202528/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202412/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202310/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202105/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202014/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05010015020025030035008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

187 companies in the database

Comparison with the other companies in wholesale of medical and hospital supplies based on the latest financial year.

Gross profitDKK 399.8mNo. 1 of 187
Better than 100% of the companies in the industry
EquityDKK 496.3mNo. 2 of 187
Better than 99% of the companies in the industry
Number of employees255No. 4 of 187
Better than 98% of the companies in the industry

Industry median: gross profit DKK 5.8m, net profit DKK 1.2m, equity DKK 5.4m, 5 employees.

DKK 100kDKK 795kDKK 6.3mDKK 50.3mDKK 200.3mHere
Distribution of gross profit for 179 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 200–499 employees796 companies in the comparison
No. 86of 763
Better than 89%
No. 119of 796
Better than 85%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 140of 24,791
Better than 99%
No. 387of 24,909
Better than 98%
All companies of type A/S18,025 companies in the comparison
No. 372of 17,786
Better than 98%
No. 723of 18,024
Better than 96%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of medical and hospital supplies
Gross profit
  1. Orifarm Generics A/SDKK 399.8m
  2. 3shape Trios A/SDKK 203.5m
  3. Medtronic Danmark A/SDKK 177.9m
Net profit
  1. Orifarm Generics A/SDKK 77.2m
  2. 3shape Trios A/SDKK 58.4m
  3. Medtronic Danmark A/SDKK 19.7m
Equity
  1. Orifarm Generics A/SDKK 496.3m
  2. 3shape Trios A/SDKK 121.7m
  3. Medtronic Danmark A/SDKK 141.9m
Employees
  1. Orifarm Generics A/S255
  2. 3shape Trios A/S56
  3. Medtronic Danmark A/S177

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Orifarm Generics Holding A/S100%
Orifarm Generics A/S

Management

6 active registrations

Executive management

Executive management at Orifarm Generics A/S
NameRoleAppointed
Thomas BrandhofCEO03/09/2025

Board of directors

Board of directors at Orifarm Generics A/S
NameRoleAppointed
Hans Carl Bøgh-SørensenChair of the board31/05/2011
Birgitte Bøgh-SørensenBoard member31/05/2011
Thomas BrandhofBoard member25/01/2024
Mads Fink EriksenBoard member17/03/2025
Nicki Lund KristensenBoard member20/10/2025
Founders
Anpartsselskabet Stakemann
Former management (17)
Former management at Orifarm Generics A/S
NameRoleAppointedResigned
Kim MadsenChair of the board15/10/200025/01/2001
Peter Andreas StakemannBoard member15/10/200025/01/2001
Peter Andreas StakemannDirector15/10/200025/01/2001
Annemette HellerBoard member15/10/200025/01/2001
Ole Michael FriisChair of the board25/01/200120/10/2003
Niels ThorborgBoard member25/01/200131/05/2003
Hans Carl Bøgh-SørensenCEO25/01/200124/03/2009
Per Munk LaustsenBoard member20/10/200314/04/2008
Ulrik Kronborg MarkussenBoard member20/10/200324/03/2009
Ole IbsenBoard member15/04/200805/07/2012
Jan Kruse HansenCEO24/03/200905/07/2012
Hans Christian Eberhard Groth TeisenBoard member05/07/201208/04/2014
Erik SandbergCEO05/07/201204/03/2013
Ulrik Ernst RasmussenCEO04/03/201315/05/2018
Erik SandbergBoard member08/04/201417/03/2025
Karsten HaumannCEO15/05/201803/09/2025
Dennis DencherBoard member28/01/202225/01/2024

Signing rule: Selskabet tegnes af den administrerende direktør og et bestyrelsesmedlem i forening, eller af to bestyrelsesmedlemmer i forening.

Address and production units

2 active production units

Energivej 15
5260 Odense S

Odense Municipality · Postcode 5260

Other companies at the address (5)

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
ORIFARM GENERICS A/SEnergivej 15, Lindved, 5260 Odense S2341007974198
ORIFARM GENERICS A/SGyngemose Parkvej 50, 6, 2860 Søborg411026705106

Purpose

Selskabets formål er at foretage salg af fortrinsvis generiske lægemidler i Danmark.

The purpose is quoted from the register in Danish.

Changes year by year

61 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20256 changesmanagement 5 · accounts 1
  • Nicki Lund Kristensen appointed board member
  • Thomas Brandhof appointed ceo
  • Karsten Haumann stepped down as ceo
  • Annual report for 2024 published
  • Mads Fink Eriksen appointed board member
  • Erik Sandberg stepped down as board member
20243 changesaccounts 1 · management 2
  • Annual report for 2023 published
  • Thomas Brandhof appointed board member
  • Dennis Dencher stepped down as board member
20231 changeaccounts 1
  • Annual report for 2022 published
20223 changesaccounts 1 · address 1 · management 1
  • Annual report for 2021 published
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Dennis Dencher appointed board member
20212 changesaddress 1 · accounts 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Annual report for 2020 published
20201 changeaddress 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
20191 changeaddress 1
  • Moved to Energivej 15, Lindved, 5260 Odense S
20182 changesmanagement 2
  • Karsten Haumann appointed ceo
  • Ulrik Ernst Rasmussen stepped down as ceo
20162 changescapital 1 · merger 1
  • Share capital changed from 800,000 DKK to 1,000,000 DKK
  • Merger registered in CVR
20142 changesmanagement 2
  • Erik Sandberg appointed board member
  • Hans Christian Eberhard Groth Teisen stepped down as board member
20132 changesmanagement 2
  • Ulrik Ernst Rasmussen appointed ceo
  • Erik Sandberg stepped down as ceo
20124 changesmanagement 4
  • Hans Christian Eberhard Groth Teisen appointed board member
  • Erik Sandberg appointed ceo
  • Jan Kruse Hansen stepped down as ceo
  • Ole Ibsen stepped down as board member
20112 changesmanagement 2
  • Hans Carl Bøgh-Sørensen appointed chair of the board
  • Birgitte Bøgh-Sørensen appointed board member
20093 changesmanagement 3
  • Jan Kruse Hansen appointed ceo
  • Ulrik Kronborg Markussen stepped down as board member
  • Hans Carl Bøgh-Sørensen stepped down as ceo
20083 changesindustry 1 · management 2
  • Industry changed to Wholesale of medical and hospital supplies (464620)
  • Ole Ibsen appointed board member
  • Per Munk Laustsen stepped down as board member
20071 changename 1
  • Name changed from COPYFARM A/S to ORIFARM GENERICS A/S
20042 changescapital 1 · ownership 1
  • Share capital changed from 700,000 DKK to 800,000 DKK
  • ORIFARM GENERICS HOLDING A/S registered as owner (100%)
20035 changescapital 1 · management 4
  • Share capital changed from 600,000 DKK to 700,000 DKK
  • Ulrik Kronborg Markussen appointed board member
  • Per Munk Laustsen appointed board member
  • Ole Michael Friis stepped down as chair of the board
  • Niels Thorborg stepped down as board member
20021 changecapital 1
  • Share capital changed from 500,000 DKK to 600,000 DKK
20019 changesname 1 · address 1 · management 7
  • Name changed from A/S PSE 38 NR. 2228 to COPYFARM A/S
  • Moved to Energivej 15, Lindved, 5260 Odense S
  • Ole Michael Friis appointed chair of the board
  • Niels Thorborg appointed board member
  • Hans Carl Bøgh-Sørensen appointed ceo
  • Kim Madsen stepped down as chair of the board
  • Peter Andreas Stakemann stepped down as board member
  • Annemette Heller stepped down as board member
  • Peter Andreas Stakemann stepped down as director
20005 changesfounded 1 · management 4
  • Registered as A/S PSE 38 NR. 2228
  • Kim Madsen appointed chair of the board
  • Peter Andreas Stakemann appointed board member
  • Annemette Heller appointed board member
  • Peter Andreas Stakemann appointed director

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction